Verdoorn Todd A. 4
4 · DiaMedica Therapeutics Inc. · Filed Jun 26, 2019
Insider Transaction Report
Form 4
Verdoorn Todd A.
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2019-06-24+71,025→ 71,025 totalExercise: $4.60Exp: 2029-06-23→ Common Shares (71,025 underlying)
Holdings
- 2,000
Voting Common Shares, no par value per share
Footnotes (1)
- [F1]Vests in eight nearly equal quarterly installments over two years.